Updated September 1, 2024
Go to JCI Insight's conflict-of-interest policy
Alnylam (SP Monga)
Antlera (SP Monga)
AstraZeneca (ME Snyder)
Bayer (TL Suber, SY Chan)
Bristol Myers Squibb (O. Eickelberg)
Coloma Therapeutics (T Finkel)
Corcept Therapeutics (PK Fazeli)
Crinetics (PK Fazeli)
Eli Lilly (EE Kershaw)
Fauna Bio (O. Eickelberg)
Generian Pharmaceuticals (T Finkel)
Haemonetics (MD Neal)
Haima Therapeutics (MD Neal)
Immunetrics (TR Billiar)
Instrumentation Laboratories (MD Neal)
Pfizer (A Morris, EE Kershaw)
Regeneron (EE Kershaw)
Santa Ana Bio (A Ray)
Synhale Therapeutics (SY Chan)
Takeda (MD Neal)
United Therapeutics (SY Chan)
WoodNext Foundation (SY Chan)
